Physician profile
Robert B Sarnoff
NPI 1083671960
$6,154.07
in general payments reported to CMS, 2019-2025
34 companies · $1,099 in 2025
The $1,099 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $958 · 2020: $1,480 · 2021: $660 · 2022: $684 · 2023: $658 · 2024: $615 · 2025: $1,099.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,372.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,372.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,947.21 | 2019-2025 | Ofev |
| Glaxosmithkline, LLC. | $1,336.72 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $454.01 | 2019-2025 | Tezspire, Tagrisso |
| Genzyme Corporation | $241.05 | 2019-2025 | |
| Mallinckrodt Hospital Products INC. | $233.31 | 2021-2025 | Acthar |
| Grifols USA, LLC | $202.77 | 2019-2025 | Prolastin-C Liquid |
| Actelion Pharmaceuticals US, INC. | $158.75 | 2019-2024 | Opsumit, Uptravi |
| Philips North America LLC | $142.68 | 2019-2025 | Encore, (O58) Sleep Respiratory Care Und |
| Harmony Biosciences LLC | $129.53 | 2024 | |
| Pfizer INC. | $125.50 | 2019-2025 | |
| Advanced Respiratory, INC | $121.02 | 2021 | |
| Janssen Biotech, INC. | $89.40 | 2019 | |
| Verona Pharma, INC. | $86.83 | 2025 | Ohtuvayre |
| Iovance Biotherapeutics, INC. | $86.62 | 2025 | Amtagvi |
| Mylan Specialty L.P. | $77.15 | 2019 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $73.67 | 2024-2025 | Dupixent, Libtayo |
| Electromed, INC. | $64.14 | 2019-2023 | Smartvest |
| Insmed, INC. | $61.21 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $57.39 | 2023-2024 | Winrevair, Dificid, Zerbaxa |
| United Therapeutics Corporation | $55.75 | 2019-2023 | Tyvaso |
| Pinnacle Biologics, INC | $55.00 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $43.30 | 2019 | |
| Sobi, INC | $42.25 | 2021-2023 | |
| Gilead Sciences, INC. | $37.77 | 2019-2025 | Veklury |
| Vapotherm INC | $33.13 | 2022 | |
| Shire North American Group INC | $31.19 | 2019 | |
| Janssen Pharmaceuticals, INC | $30.23 | 2019-2023 | Xarelto |
| Incyte Corporation | $26.35 | 2024 | Jakafi |
| Bayer Healthcare Pharmaceuticals INC. | $21.68 | 2025 | |
| Genentech USA, INC. | $21.14 | 2020 | |
| Ani Pharmaceuticals, INC. | $20.18 | 2025 | Purified Cortrophin Gel |
| Caris Mpi, INC. | $18.45 | 2025 | Mi Cancer Seek |
| Arbor Pharmaceuticals, INC. | $14.67 | 2019 | |
| Amgen INC. | $14.02 | 2025 | Tezspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Sarnoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.